W. Schütte

445 total citations
8 papers, 40 citations indexed

About

W. Schütte is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Nephrology. According to data from OpenAlex, W. Schütte has authored 8 papers receiving a total of 40 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 1 paper in Nephrology. Recurrent topics in W. Schütte's work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Lung Cancer Research Studies (2 papers). W. Schütte is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Lung Cancer Research Studies (2 papers). W. Schütte collaborates with scholars based in Germany and United States. W. Schütte's co-authors include J. McCoy, Vivek Charu, István Albert, Daniel Berger, B Osten, A. Chemaissani, Monika I. Leschinger, Gerald Schmid‐Bindert, J.R. Fischer and Núria Viñolas and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Lung Cancer.

In The Last Decade

W. Schütte

8 papers receiving 40 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Schütte Germany	4	20	14	11	9	5	8	40
David Philibert Canada	5	16 0.8×	7 0.5×	13 1.2×	42 4.7×	5 1.0×	5	61
Margarita Askelson United States	5	15 0.8×	19 1.4×	12 1.1×	7 0.8×	1 0.2×	16	47
Catherine Sperlich Canada	4	19 0.9×	10 0.7×	7 0.6×	1 0.1×	4 0.8×	8	33
F. Duchêne France	3	12 0.6×	8 0.6×	2 0.2×	8 0.9×	3 0.6×	5	45
Fabio Lizzi Germany	3	9 0.5×	3 0.2×	25 2.3×	23 2.6×	16 3.2×	3	40
Muhammad Saad Hamid United States	4	19 0.9×	15 1.1×	3 0.3×		2 0.4×	10	36
Christopher H. Yoo United States	3	18 0.9×	9 0.6×	5 0.5×		2 0.4×	8	33
Takehiko Ohba Japan	4	35 1.8×	8 0.6×		5 0.6×	7 1.4×	6	43
Hiraku Ogata Japan	3	5 0.3×	6 0.4×	6 0.5×	17 1.9×	3 0.6×	9	34
Andrew Drummond United Kingdom	2	12 0.6×	37 2.6×	2 0.2×	5 0.6×	1 0.2×	2	39

Countries citing papers authored by W. Schütte

Since Specialization

Citations

This map shows the geographic impact of W. Schütte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Schütte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Schütte more than expected).

Fields of papers citing papers by W. Schütte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Schütte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Schütte. The network helps show where W. Schütte may publish in the future.

Co-authorship network of co-authors of W. Schütte

This figure shows the co-authorship network connecting the top 25 collaborators of W. Schütte. A scholar is included among the top collaborators of W. Schütte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Schütte. W. Schütte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Eberhardt, Wilfried, Marc A. Thomas, J. - Matthias Graf von der Schulenburg, et al.. (2011). 9144 POSTER EGFR Mutation Testing and First Line Treatment of Patients With Advanced NSCLC and Positive EGFR Mutation Status – Results From a German Registry. European Journal of Cancer. 47. S636–S636. 3 indexed citations

2.

Blankenburg, Thomas, Birgit Gottschlich, W. Schütte, H Neef, & Johannes Haerting. (2010). Prognostische Relevanz der Metastasenlokalisation bei nicht kleinzelligem Bronchialkarzinom im Tumorstadium IV – Ergebnisse einer prospektiven epidemiologischen Studie. Pneumologie. 64(11). 679–685. 1 indexed citations

3.

Schmid‐Bindert, Gerald, A. Chemaissani, J.R. Fischer, et al.. (2009). Pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in early-stage NSCLC. Journal of Clinical Oncology. 27(15_suppl). 7565–7565. 10 indexed citations

4.

Charu, Vivek, et al.. (2009). 9248 Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC). European Journal of Cancer Supplements. 7(2). 574–574. 11 indexed citations

5.

Nagel, S., et al.. (2005). Second-line-Behandlung des malignen Pleuramesothelioms mit Pemetrexed (Alimta®) - eine Kasuistik. Pneumologie. 59(2). 108–111. 1 indexed citations

6.

Schütte, W., et al.. (1997). Phase II trial of docetaxel and carboplatin in the treatment of advanced non-small cell lung cancer. European Journal of Cancer. 33. S238–S238. 2 indexed citations

7.

Schütte, W., et al.. (1997). Paraneoplastic IgA nephritis as initial symptom of a bronchial carcinoma. Lung Cancer. 16(2-3). 272–272. 10 indexed citations

8.

Schütte, W., et al.. (1995). 1107 Paclitaxel single agent in the first-line treatment of advanced NSCLC. European Journal of Cancer. 31. S230–S231. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact